Omicia, located in Oakland, California, is currently hiring for several open positions, including bioinformaticians, data scientists and quality assurance engineers.
Omicia is hiring a Bioinformaticist who will drive the design of our market leading annotation and analysis pipelines. You will collaborate with other scientists, developers and users to develop novel techniques for analyzing genomic data with the goal of developing actionable insight on genomic data. We are looking for eager and hands-on candidates who can work effectively in a dynamic startup environment, and want to help shape the future of personalized medicine.
Bioinformatics Quallity Engineer:
Omicia is hiring a Bioinformatics Quality Engineer who will drive the design and execution of testing protocols to validate Omicia’s Bioinformatics pipelines, datasets, and applications.You will collaborate with other scientists, developers, and users to ensure that Omicia’s software meets quality and compliance requirements. We are looking for hands-on candidates who can work effectively in a dynamic startup environment.
These jobs and others are posted at https://jobs.lever.co/omicia
Omicia is unlocking the potential of individualized medicine. Our mission is to help researchers and clinicians understand and apply the most relevant information from personal genome sequences, to improve disease management and medical outcomes.
Researchers and clinical diagnostic organizations use our solutions to analyze and identify the genetic basis of a variety of conditions, including childhood disease, cancer and cardiovascular disease. Opal™, the leading platform for fast, accurate and flexible genome analysis, enables clinicians, researchers and bioinformaticians alike to derive clinically relevant insights from genomic data. VAAST, our robust novel disease gene finder and variant scoring algorithm, is in use at more than 300 academic and clinical institutions including the NIH, the University of Oxford, the University of Cambridge, Seattle Children’s Research Institute, Institut Pasteur, University of Maryland Institute for Genome Sciences, and UCSF.